Interactions médicamenteuses
Bazedoxifene-conjugated estrogens + Lonapegsomatropin
Gravité: Modérée
Bazedoxifene-conjugated estrogens and Lonapegsomatropin: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Oral estrogens reduce the hepatic production of IGF-1 in response to growth hormone, so the biological effect of lonapegsomatropin may be blunted. Patients may need a higher growth hormone dose to reach their IGF-1 target.
Ce que signifie cette interaction, en termes simples
Bazedoxifene-conjugated estrogens and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bazedoxifene-conjugated estrogens belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.
Pourquoi elle survient
Oral estrogen exposure of the liver suppresses growth hormone-induced IGF-1 generation, causing partial growth hormone resistance.
Conduite à tenir
Monitor serum IGF-1 and clinical response when starting or stopping the estrogen-containing product, and titrate lonapegsomatropin dose accordingly.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Bazedoxifene-conjugated estrogens et Lonapegsomatropin, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres interactions de Bazedoxifene-conjugated estrogens
- Anastrozole + Bazedoxifene-conjugated estrogens Contre-indiquée
- Bazedoxifene-conjugated estrogens + Ospemifene Contre-indiquée
- Antithrombin alfa + Bazedoxifene-conjugated estrogens Majeure
- Antithrombin iii + Bazedoxifene-conjugated estrogens Majeure
- Bazedoxifene-conjugated estrogens + Bemiparin Majeure
- Bazedoxifene-conjugated estrogens + Carbamazepine Majeure
Autres interactions de Lonapegsomatropin
Questions fréquentes
Can I take Bazedoxifene-conjugated estrogens with Lonapegsomatropin?
MediHelp rates the interaction as moderate. Bazedoxifene-conjugated estrogens and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oral estrogens reduce the hepatic production of IGF-1 in response to growth hormone, so the biological effect of lonapegsomatropin may be blunted. Patients may need a higher growth hormone dose to reach their IGF-1 target.
How serious is the interaction between Bazedoxifene-conjugated estrogens and Lonapegsomatropin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum IGF-1 and clinical response when starting or stopping the estrogen-containing product, and titrate lonapegsomatropin dose accordingly.
What other medicines interact with Bazedoxifene-conjugated estrogens?
MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
